Drug
Ecnoglutide
Ecnoglutide: highest development phase Phase 2, developed by Hangzhou Sciwind Biosciences Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hangzhou Sciwind Biosciences Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ecnoglutide tablet NCT07929298 | Phase 2 | Overweight , Obesity |
Latest
No recent events.
Follow Ecnoglutide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.